Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1976 1
1977 1
1979 1
1980 2
1981 3
1982 4
1983 6
1984 6
1985 5
1986 4
1987 13
1988 18
1989 17
1990 8
1991 15
1992 11
1993 3
1994 7
1995 6
1996 10
1997 6
1998 9
1999 2
2000 15
2001 9
2002 9
2003 13
2004 4
2005 10
2006 12
2007 17
2008 3
2009 9
2010 11
2011 10
2012 8
2013 10
2014 11
2015 7
2016 5
2017 9
2018 12
2019 1
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

327 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy of anti-PD-1/PD-L1 antibodies after discontinuation due to adverse events in non-small cell lung cancer patients (HANSHIN 0316).
Tachihara M, Negoro S, Inoue T, Tamiya M, Akazawa Y, Uenami T, Urata Y, Hattori Y, Hata A, Katakami N, Yokota S. Tachihara M, et al. Among authors: Negoro S. BMC Cancer. 2018 Oct 3;18(1):946. doi: 10.1186/s12885-018-4819-2. BMC Cancer. 2018. PMID: 30285770 Free PMC article.
Afatinib plus bevacizumab combination after acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer: Multicenter, single-arm, phase 2 trial (ABC Study).
Hata A, Katakami N, Kaji R, Yokoyama T, Kaneda T, Tamiya M, Inoue T, Kimura H, Yano Y, Tamura D, Morita S, Negoro S, The Hanshin Oncology Group F. Hata A, et al. Among authors: Negoro S. Cancer. 2018 Oct 1;124(19):3830-3838. doi: 10.1002/cncr.31678. Epub 2018 Sep 7. Cancer. 2018. PMID: 30192383 Free article. Clinical Trial.
Does afatinib plus bevacizumab combination therapy induce positive conversion of T790M in previously-negative patients?
Hata A, Katakami N, Kaji R, Yokoyama T, Kaneda T, Tamiya M, Inoue T, Kimura H, Yano Y, Tamura D, Morita S, Negoro S; HANSHIN Oncology Group. Hata A, et al. Among authors: Negoro S. Oncotarget. 2018 Oct 5;9(78):34765-34771. doi: 10.18632/oncotarget.26192. eCollection 2018 Oct 5. Oncotarget. 2018. PMID: 30410675 Free PMC article.
Combined analysis of V20, VS5, pulmonary fibrosis score on baseline computed tomography, and patient age improves prediction of severe radiation pneumonitis after concurrent chemoradiotherapy for locally advanced non-small-cell lung cancer.
Tsujino K, Hashimoto T, Shimada T, Yoden E, Fujii O, Ota Y, Satouchi M, Negoro S, Adachi S, Soejima T. Tsujino K, et al. Among authors: Negoro S. J Thorac Oncol. 2014 Jul;9(7):983-990. doi: 10.1097/JTO.0000000000000187. J Thorac Oncol. 2014. PMID: 24922010 Free article.
Randomized Phase III Study Comparing Gefitinib With Erlotinib in Patients With Previously Treated Advanced Lung Adenocarcinoma: WJOG 5108L.
Urata Y, Katakami N, Morita S, Kaji R, Yoshioka H, Seto T, Satouchi M, Iwamoto Y, Kanehara M, Fujimoto D, Ikeda N, Murakami H, Daga H, Oguri T, Goto I, Imamura F, Sugawara S, Saka H, Nogami N, Negoro S, Nakagawa K, Nakanishi Y. Urata Y, et al. Among authors: Negoro S. J Clin Oncol. 2016 Sep 20;34(27):3248-57. doi: 10.1200/JCO.2015.63.4154. Epub 2016 Mar 28. J Clin Oncol. 2016. PMID: 27022112 Clinical Trial.
Phase II trial of gefitinib plus pemetrexed after relapse using first-line gefitinib in patients with non-small cell lung cancer harboring EGFR gene mutations.
Uchibori K, Satouchi M, Sueoka-Aragane N, Urata Y, Sato A, Imamura F, Inoue T, Tachihara M, Kobayashi K, Katakami N, Kokan C, Hirashima T, Iwanaga K, Mori M, Aoe K, Morita S, Negoro S. Uchibori K, et al. Among authors: Negoro S. Lung Cancer. 2018 Oct;124:65-70. doi: 10.1016/j.lungcan.2018.07.031. Epub 2018 Jul 23. Lung Cancer. 2018. PMID: 30268482 Clinical Trial.
4-step 4-h carboplatin desensitization protocol for patients with gynecological malignancies showing platinum hypersensitivity: a retrospective study.
Takase N, Matsumoto K, Onoe T, Kitao A, Tanioka M, Kikukawa Y, Yamaguchi S, Fujiwara K, Negoro S. Takase N, et al. Among authors: Negoro S. Int J Clin Oncol. 2015 Jun;20(3):566-73. doi: 10.1007/s10147-014-0731-1. Epub 2014 Jul 18. Int J Clin Oncol. 2015. PMID: 25030546
327 results
Jump to page
Feedback